Amyotrophic lateral sclerosis.

Amyotrophic lateral sclerosis (ALS) is a common neurological disorder that results in loss of motor neurons, leading to a rapidly progressive form of muscle paralysis that is fatal. There is no available cure and current therapies only provide minimal benefit at best. The disease is predominantly sporadic and until very recently only the Cu,Zn superoxide dismutase (Cu,ZnSOD), which is involved in a small number of sporadic cases and a larger component of familial ones, have been analyzed in any detail. Here we describe the clinical aspects of ALS and highlight the genetics and molecular mechanisms behind the disease. We discuss the current understanding and controversies of how mutations in Cu,ZnSOD may cause the disease. We also focus on the recent discovery that mutations in either TDP-43 or FUS/TLS, which are both involved in DNA/RNA synthesis, are likely the cause behind many cases of ALS that are not linked to Cu,ZnSOD.

[1]  E. Goodall,et al.  Genetics of Familial Amyotrophic Lateral Sclerosis , 2012 .

[2]  David Heckerman,et al.  A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.

[3]  J. Julien,et al.  Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments. , 2011, Brain : a journal of neurology.

[4]  J. Haines,et al.  Mutations in UBQLN2 cause dominant X-linked juvenile and adult onset ALS and ALS/dementia , 2011, Nature.

[5]  V. Gribkoff,et al.  Safety, Tolerability, and Pharmacokinetics of KNS‐760704 (Dexpramipexole) in Healthy Adult Subjects , 2011, Journal of clinical pharmacology.

[6]  Christopher Kennard,et al.  Oculomotor dysfunction in amyotrophic lateral sclerosis: a comprehensive review. , 2011, Archives of neurology.

[7]  C. Haass,et al.  TDP-43 and FUS: a nuclear affair , 2011, Trends in Neurosciences.

[8]  A. Kuhlmey,et al.  Delay in diagnosis of muscle disorders depends on the subspecialty of the initially consulted physician , 2011, BMC health services research.

[9]  E. Huey,et al.  FTD and ALS: a tale of two diseases. , 2011, Current Alzheimer research.

[10]  C. Heckman,et al.  Stronger is not always better: Could a bodybuilding dietary supplement lead to ALS? , 2011, Experimental Neurology.

[11]  R. Reiter,et al.  Levels of membrane fluidity in the spinal cord and the brain in an animal model of amyotrophic lateral sclerosis , 2011, Journal of bioenergetics and biomembranes.

[12]  A. Chiò,et al.  Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[13]  S. Messina,et al.  The diagnosis of Amyotrophic lateral sclerosis in 2010. , 2011, Archives italiennes de biologie.

[14]  R. Takahashi,et al.  Optineurin is co-localized with FUS in basophilic inclusions of ALS with FUS mutation and in basophilic inclusion body disease , 2011, Acta Neuropathologica.

[15]  M. Thun,et al.  Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of 5 prospective cohorts. , 2011, Archives of neurology.

[16]  R. Baloh,et al.  Implications of the prion-related Q/N domains in TDP-43 and FUS , 2011, Prion.

[17]  K. Wada,et al.  TDP-43 physically interacts with amyotrophic lateral sclerosis-linked mutant CuZn superoxide dismutase , 2010, Neurochemistry International.

[18]  Pamela A McCombe,et al.  Effects of gender in amyotrophic lateral sclerosis. , 2010, Gender medicine.

[19]  K. Talbot Do twin studies still have anything to teach us about the genetics of amyotrophic lateral sclerosis? , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[20]  O. Hardiman,et al.  Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[21]  G. Bernardi,et al.  Increased levels of p70S6 phosphorylation in the G93A mouse model of Amyotrophic Lateral Sclerosis and in valine-exposed cortical neurons in culture , 2010, Experimental Neurology.

[22]  Robert H. Brown,et al.  Screening for inhibitors of the SOD1 gene promoter: Pyrimethamine does not reduce SOD1 levels in cell and animal models , 2010, Neuroscience Letters.

[23]  I. Mackenzie,et al.  TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia , 2010, The Lancet Neurology.

[24]  J. Tainer,et al.  Characterization of a Y-Family DNA Polymerase eta from the Eukaryotic Thermophile Alvinella pompejana , 2010, Journal of nucleic acids.

[25]  J. Lachey,et al.  Administration of a soluble activin type IIB receptor promotes skeletal muscle growth independent of fiber type. , 2010, Journal of applied physiology.

[26]  V. Olkkonen,et al.  ALS-linked P56S-VAPB, an aggregated loss-of-function mutant of VAPB, predisposes motor neurons to ER stress-related death by inducing aggregation of co-expressed wild-type VAPB. , 2010, Journal of neurochemistry.

[27]  I. Mackenzie,et al.  ALS‐associated fused in sarcoma (FUS) mutations disrupt Transportin‐mediated nuclear import , 2010, The EMBO journal.

[28]  R. Tibbetts,et al.  Amyotrophic Lateral Sclerosis-associated Proteins TDP-43 and FUS/TLS Function in a Common Biochemical Complex to Co-regulate HDAC6 mRNA* , 2010, The Journal of Biological Chemistry.

[29]  Huilin Zhou,et al.  ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS , 2010, Proceedings of the National Academy of Sciences.

[30]  S. Sathasivam Motor neurone disease: clinical features, diagnosis, diagnostic pitfalls and prognostic markers. , 2010, Singapore medical journal.

[31]  S. Schmidt,et al.  Association of ALS with head injury, cigarette smoking and APOE genotypes , 2010, Journal of the Neurological Sciences.

[32]  D. Cleveland,et al.  TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. , 2010, Human molecular genetics.

[33]  J. Tainer,et al.  The structural biochemistry of the superoxide dismutases. , 2010, Biochimica et biophysica acta.

[34]  M. Strong The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS) , 2010, Journal of the Neurological Sciences.

[35]  M. Hernán,et al.  Association of smoking with amyotrophic lateral sclerosis risk and survival in men and women: a prospective study , 2010, BMC neurology.

[36]  C. Armon Smoking may be considered an established risk factor for sporadic ALS , 2009, Neurology.

[37]  P. Lamberti,et al.  Current and emerging treatments for amyotrophic lateral sclerosis , 2009, Neuropsychiatric disease and treatment.

[38]  Hyoung-Gon Lee,et al.  All-trans retinoic acid as a novel therapeutic strategy for Alzheimer’s disease , 2009, Expert review of neurotherapeutics.

[39]  M. Hernán,et al.  Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population‐based study , 2009, European journal of neurology.

[40]  S. Sasaki,et al.  Lifestyle factors and risk of amyotrophic lateral sclerosis: a case-control study in Japan. , 2009, Annals of epidemiology.

[41]  Michel Dib,et al.  Biomarkers in Amyotrophic Lateral Sclerosis , 2009, Molecular Diagnosis & Therapy.

[42]  D. Cleveland,et al.  Rethinking ALS: The FUS about TDP-43 , 2009, Cell.

[43]  Myoung-Eun Han,et al.  Reduction of ischemia-induced cerebral injury by all-trans-retinoic acid , 2009, Experimental Brain Research.

[44]  Xun Hu,et al.  Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 , 2009, Science.

[45]  J L Haines,et al.  Supporting Online Material Materials and Methods Figs. S1 to S7 Tables S1 to S4 References Mutations in the Fus/tls Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis , 2022 .

[46]  John A Tainer,et al.  Superoxide dismutase from the eukaryotic thermophile Alvinella pompejana: structures, stability, mechanism, and insights into amyotrophic lateral sclerosis. , 2009, Journal of molecular biology.

[47]  J. Yates,et al.  Progressive aggregation despite chaperone associations of a mutant SOD1-YFP in transgenic mice that develop ALS , 2009, Proceedings of the National Academy of Sciences.

[48]  M. Miranda,et al.  Spatial analysis of the etiology of amyotrophic lateral sclerosis among 1991 Gulf War veterans. , 2008, Neurotoxicology.

[49]  B. Kalmar,et al.  Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1G93A mouse model of ALS , 2008, Journal of neurochemistry.

[50]  V. Gribkoff,et al.  KNS‐760704 [(6R)‐4,5,6,7‐tetrahydro‐N6‐propyl‐2, 6‐benzothiazole‐diamine dihydrochloride monohydrate] for the Treatment of Amyotrophic Lateral Sclerosis , 2008, CNS neuroscience & therapeutics.

[51]  Hynek Wichterle,et al.  Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons , 2008, Science.

[52]  A. Riecker,et al.  Diagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis , 2008, Nature Clinical Practice Neurology.

[53]  S. Grambow,et al.  Amyotrophic Lateral Sclerosis among 1991 Gulf War Veterans: Evidence for a Time-Limited Outbreak , 2008, Neuroepidemiology.

[54]  Takanori Yokota,et al.  Als-linked Mutant Sod1 Induces Er Stress-and Ask1-dependent Motor Neuron Death by Targeting Derlin-1 -induced Cell Death Remains Controversial. Here We Show That Sod1 Mut Specifically Interacted with Derlin-1, a Component of Endoplasmic Reticulum (er)-associated Degradation (erad) Machinery and Trig , 2022 .

[55]  C. Lomen‐Hoerth,et al.  Amyotrophic Lateral Sclerosis from Bench to Bedside , 2008, Seminars in neurology.

[56]  Tom Misteli,et al.  TDP-43 regulates retinoblastoma protein phosphorylation through the repression of cyclin-dependent kinase 6 expression , 2008, Proceedings of the National Academy of Sciences.

[57]  M. Swash,et al.  Electrodiagnostic criteria for diagnosis of ALS , 2008, Clinical Neurophysiology.

[58]  H. Paulson,et al.  SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. , 2008, The Journal of clinical investigation.

[59]  J. E. Kranz,et al.  Design, power, and interpretation of studies in the standard murine model of ALS , 2008, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[60]  P. Reddi,et al.  A Novel CpG-free Vertebrate Insulator Silences the Testis-specific SP-10 Gene in Somatic Tissues , 2007, Journal of Biological Chemistry.

[61]  J. Trojanowski,et al.  TDP-43 Proteinopathies: Neurodegenerative Protein Misfolding Diseases without Amyloidosis , 2007, Neurosignals.

[62]  A. Al-Chalabi,et al.  Amyotrophic Lateral Sclerosis in South-East England: A Population-Based Study , 2007, Neuroepidemiology.

[63]  J. Alappat ETHNIC VARIATION IN THE INCIDENCE OF ALS: A SYSTEMATIC REVIEW , 2007, Neurology.

[64]  Asako Otomo,et al.  Molecular and cellular function of ALS2/alsin: Implication of membrane dynamics in neuronal development and degeneration , 2007, Neurochemistry International.

[65]  P. Wicks Excessive yawning is common in the bulbar‐onset form of ALS , 2007, Acta psychiatrica Scandinavica.

[66]  L. Hayward,et al.  Interaction between Familial Amyotrophic Lateral Sclerosis (ALS)-linked SOD1 Mutants and the Dynein Complex* , 2007, Journal of Biological Chemistry.

[67]  E. Abel Football Increases the Risk for Lou Gehrig's Disease, Amyotrophic Lateral Sclerosis , 2007, Perceptual and motor skills.

[68]  M. Strong,et al.  TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein , 2007, Molecular and Cellular Neuroscience.

[69]  B. Traynor,et al.  Emerging disease-modifying therapies for the treatment of motor neuron disease/amyotropic lateral sclerosis , 2007, Expert opinion on emerging drugs.

[70]  M. Benatar Lost in translation: Treatment trials in the SOD1 mouse and in human ALS , 2007, Neurobiology of Disease.

[71]  P. Garagnani,et al.  Simple method for haplotyping the poly(TG) repeat in individuals carrying the IVS8 5T allele in the CFTR gene. , 2007, Clinical chemistry.

[72]  R. Henry,et al.  Establishing subtypes of the continuum of frontal lobe impairment in amyotrophic lateral sclerosis. , 2007, Archives of neurology.

[73]  H. Akiyama,et al.  TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. , 2006, Biochemical and biophysical research communications.

[74]  J. Zhu,et al.  Amyotrophic Lateral Sclerosis 2-Deficiency Leads to Neuronal Degeneration in Amyotrophic Lateral Sclerosis through Altered AMPA Receptor Trafficking , 2006, The Journal of Neuroscience.

[75]  V. Koliatsos,et al.  Human Neural Stem Cell Grafts Ameliorate Motor Neuron Disease in SOD-1 Transgenic Rats , 2006, Transplantation.

[76]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[77]  D. Cleveland,et al.  ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors , 2006, Neuron.

[78]  Robert H. Brown,et al.  Molecular biology of amyotrophic lateral sclerosis: insights from genetics , 2006, Nature Reviews Neuroscience.

[79]  B. Monia,et al.  Antisense oligonucleotide therapy for neurodegenerative disease. , 2006, The Journal of clinical investigation.

[80]  G. Hicks,et al.  TLS, EWS and TAF15: a model for transcriptional integration of gene expression. , 2006, Briefings in functional genomics & proteomics.

[81]  R. Olney,et al.  The effects of executive and behavioral dysfunction on the course of ALS , 2005, Neurology.

[82]  P. Andersen,et al.  EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives , 2005, European journal of neurology.

[83]  S. Reske,et al.  Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD , 2005, Annals of neurology.

[84]  B. Schürmann,et al.  The Oral Antidiabetic Pioglitazone Protects from Neurodegeneration and Amyotrophic Lateral Sclerosis-Like Symptoms in Superoxide Dismutase-G93A Transgenic Mice , 2005, The Journal of Neuroscience.

[85]  P. Ince,et al.  Return of the cycad hypothesis – does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health? , 2005, Neuropathology and applied neurobiology.

[86]  L. Greensmith,et al.  A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice , 2005, The Journal of cell biology.

[87]  M. Wicklund Amyotrophic lateral sclerosis: possible role of environmental influences. , 2005, Neurologic clinics.

[88]  G. Hicks,et al.  The RNA Binding Protein TLS Is Translocated to Dendritic Spines by mGluR5 Activation and Regulates Spine Morphology , 2005, Current Biology.

[89]  S. Cary,et al.  The splicing factor U2AF65 is functionally conserved in the thermotolerant deep-sea worm Alvinella pompejana. , 2005, Biochimica et biophysica acta.

[90]  A. Chiò,et al.  Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. , 2005, Brain : a journal of neurology.

[91]  P. Sarradin,et al.  Thermal selection of PGM allozymes in newly founded populations of the thermotolerant vent polychaete Alvinella pompejana , 2004, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[92]  A. Ludolph,et al.  Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model , 2004, Journal of Neurology.

[93]  A. Ludolph,et al.  Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS , 2004, Neurology.

[94]  R. Forbes,et al.  The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 or over. , 2004, Age and ageing.

[95]  A. Hays,et al.  Expression of peripherin in ubiquinated inclusions of amyotrophic lateral sclerosis , 2004, Journal of the Neurological Sciences.

[96]  G. Filippini,et al.  Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period , 2004, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[97]  E. Bertini,et al.  Unstable mutants in the peripheral endosomal membrane component ALS2 cause early-onset motor neuron disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[98]  John A Tainer,et al.  ALS mutants of human superoxide dismutase form fibrous aggregates via framework destabilization. , 2003, Journal of molecular biology.

[99]  L. Salminen,et al.  Glutamate uptake is inhibited by tamoxifen and toremifene in cultured retinal pigment epithelial cells. , 2002, Pharmacology & toxicology.

[100]  C. Dobson Protein folding and its links with human disease. , 2002, Biochemical Society symposium.

[101]  J. Joseph,et al.  Bicarbonate Enhances Peroxidase Activity of Cu,Zn-Superoxide Dismutase , 2002, The Journal of Biological Chemistry.

[102]  P. Worms The epidemiology of motor neuron diseases: a review of recent studies , 2001, Journal of the Neurological Sciences.

[103]  S. Sakoda,et al.  Copper chaperone for superoxide dismutase co-aggregates with superoxide dismutase 1 (SOD1) in neuronal Lewy body-like hyaline inclusions: an immunohistochemical study on familial amyotrophic lateral sclerosis with SOD1 gene mutation , 2001, Acta Neuropathologica.

[104]  C. Soto,et al.  Protein misfolding and disease; protein refolding and therapy , 2001, FEBS letters.

[105]  M. Gurney,et al.  Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[106]  E. Wanker Protein aggregation in Huntington's and Parkinson's disease: implications for therapy. , 2000, Molecular medicine today.

[107]  K. Fischbeck,et al.  A gene for autosomal dominant juvenile amyotrophic lateral sclerosis (ALS4 ) localizes to a 500-kb interval on chromosome 9q34 , 2000, Neurogenetics.

[108]  T. Burjanadze New analysis of the phylogenetic change of collagen thermostability. , 2000, Biopolymers.

[109]  P. Andersen,et al.  Genetic factors in the early diagnosis of ALS , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[110]  M. Swash,et al.  El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[111]  A. Chiò ISIS Survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis , 1999, Journal of Neurology.

[112]  J. Cedarbaum,et al.  The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function , 1999, Journal of the Neurological Sciences.

[113]  J. Shefner,et al.  Association of Cigarette Smoking with Amyotrophic Lateral Sclerosis , 1999, Neuroepidemiology.

[114]  A. Ludolph,et al.  Problems and pitfalls in the diagnosis of ALS , 1999, Journal of the Neurological Sciences.

[115]  A Al-Chalabi,et al.  Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. , 1999, Human molecular genetics.

[116]  Michael Swash,et al.  Early diagnosis of ALS/MND , 1998, Journal of the Neurological Sciences.

[117]  L. Bruijn,et al.  Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. , 1998, Science.

[118]  S. Barnes,et al.  Superoxide Dismutase Catalyzes Nitration of Tyrosines by Peroxynitrite in the Rod and Head Domains of Neurofilament‐L , 1997, Journal of neurochemistry.

[119]  D. Figlewicz,et al.  Aggregation of Mutant Cu/Zn Superoxide Dismutase Proteins in a Culture Model of ALS , 1997, Journal of neuropathology and experimental neurology.

[120]  P. Andersen,et al.  Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients. , 1996, Brain : a journal of neurology.

[121]  M. Beal,et al.  Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury , 1996, Nature Genetics.

[122]  C. Warlow,et al.  Avoiding false positive diagnoses of motor neuron disease: lessons from the Scottish Motor Neuron Disease Register. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[123]  D. Bredesen,et al.  Altered Reactivity of Superoxide Dismutase in Familial Amyotrophic Lateral Sclerosis , 1996, Science.

[124]  D. Borchelt,et al.  Motor neuron disease caused by mutations in superoxide dismutase 1. , 1995, Current opinion in neurology.

[125]  S H Appel,et al.  Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. , 1995, Brain : a journal of neurology.

[126]  Robert H. Brown,et al.  Amyotrophic lateral sclerosis: Recent insights from genetics and transgenic mice , 1995, Cell.

[127]  M. Gurney,et al.  Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.

[128]  M. Pericak-Vance,et al.  Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. , 1993, Science.

[129]  M. Carson,et al.  ALS, SOD and peroxynitrite , 1993, Nature.

[130]  N. Mandahl,et al.  Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma , 1993, Nature.

[131]  R. Larson,et al.  Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma , 1993, Nature Genetics.

[132]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[133]  M. Beal Mechanisms of excitotoxicity in neurologic diseases , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[134]  E. Getzoff,et al.  Faster superoxide dismutase mutants designed by enhancing electrostatic guidance , 1992, Nature.

[135]  J. Tainer,et al.  Atomic structures of wild-type and thermostable mutant recombinant human Cu,Zn superoxide dismutase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[136]  J. Tainer,et al.  Thermostabilization of recombinant human and bovine CuZn superoxide dismutases by replacement of free cysteines. , 1991, Biochemical and biophysical research communications.

[137]  M. Swash,et al.  Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity. , 1991, Brain : a journal of neurology.

[138]  G. Bruyn,et al.  Autosomal dominant adult amyotrophic lateral sclerosis A six generation dutch family , 1990, Journal of the Neurological Sciences.

[139]  M. Hamida,et al.  Hereditary motor system diseases (chronic juvenile amyotrophic lateral sclerosis). Conditions combining a bilateral pyramidal syndrome with limb and bulbar amyotrophy. , 1990, Brain : a journal of neurology.

[140]  D. B. Williams,et al.  Familial motor neuron disease: Differing penetrance in large pedigrees , 1988, Journal of the Neurological Sciences.

[141]  M. Swash,et al.  Comparison of sporadic and familial disease amongst 580 cases of motor neuron disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[142]  L. Kurland,et al.  Familial adult motor neuron disease: amyotrophic lateral sclerosis , 1986, Neurology.

[143]  R. Palm,et al.  Motor Neuron Disease and Heavy Manual Labor: An Epidemiologic Survey of Värmland County, Sweden , 1984 .

[144]  Peter A. Kollman,et al.  Electrostatic recognition between superoxide and copper, zinc superoxide dismutase , 1983, Nature.

[145]  John A. Tainer,et al.  Structure and mechanism of copper, zinc superoxide dismutase , 1983, Nature.

[146]  L. Forsgren,et al.  Epidemiology of motor neuron disease in northern Sweden , 1983, Acta neurologica Scandinavica.

[147]  R. Fogelholm,et al.  Amyotrophic lateral sclerosis in Middle‐Finland: an epidemiological study , 1983, Acta neurologica Scandinavica.

[148]  J. Richardson,et al.  Determination and analysis of the 2 A-structure of copper, zinc superoxide dismutase. , 1980, Journal of molecular biology.

[149]  I. Fridovich,et al.  Subunit association and side-chain reactivities of bovine erythrocyte superoxide dismutase in denaturing solvents. , 1979, Biochemistry.

[150]  J. Brody,et al.  Familial motor neuron disease , 1976, Neurology.

[151]  I. Fridovich,et al.  On the stability of bovine superoxide dismutase. The effects of metals. , 1973, The Journal of biological chemistry.

[152]  L. Olivares,et al.  Mexican "resistance" to amyotrophic lateral sclerosis. , 1972, Archives of neurology.

[153]  W. Haberlandt Genetic aspects of amyotrophic lateral sclerosis and progressive bulbar paralysis. , 1959, Acta geneticae medicae et gemellologiae.

[154]  J. Folch,et al.  CEREBROCUPREIN I. A COPPER‐CONTAINING PROTEIN ISOLATED FROM BRAIN , 1957, Journal of neurochemistry.

[155]  D. Keilin,et al.  Haemocuprein and Hepatocuprein, Copper-Protein Compounds of Blood and Liver in Mammals , 1938 .

[156]  A. Ludolph,et al.  Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.

[157]  D. Annane,et al.  Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. , 2009, The Cochrane database of systematic reviews.

[158]  W. Bradley,et al.  The ALS/PDC syndrome of Guam and the cycad hypothesis. , 2009, Neurology.

[159]  P. Andersen Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene , 2006, Current neurology and neuroscience reports.

[160]  A. Sik,et al.  Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis , 2006, Nature Neuroscience.

[161]  W. Burke Neuroprotective agents for clinical trials in ALS: systematic assessment. , 2006, Neurology.

[162]  R. Miller,et al.  Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). , 2003, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[163]  S. Hadano,et al.  A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2 , 2001, Nature Genetics.

[164]  O. Hardiman,et al.  Amyotrophic lateral sclerosis mimic syndromes: a population-based study. , 2000, Archives of neurology.

[165]  T. Lam,et al.  Motor neuron disease in Hong Kong Chinese: epidemiology and clinical picture. , 1996, Neuroepidemiology.

[166]  E R James,et al.  Superoxide dismutase. , 1994, Parasitology today.

[167]  Z A Arlin,et al.  Treatment of acute promyelocytic leukemia. , 1992, Blood.

[168]  K. Purohit,et al.  Juvenile amyotrophic lateral sclerosis. , 1971, Indian pediatrics.

[169]  Jm Charcot,et al.  Deux cas d’atrophie musculaire progressive avec lesions de la substance grise et des faisceaux antero-lateraux de la moelle epiniere , 1869 .